Good morning. Welcome to the 2026 annual meeting of shareholders for Caris Life Sciences. I will now turn the line over to the Founder, Chairman, and Chief Executive Officer of Caris, David Dean Halbert. Please proceed, Mr. Halbert Good morning, and thank you for joining. On behalf of Caris Life Sciences and the members of the board, I am pleased to welcome you to our 2026 annual meeting of shareholders. Participating for management today are Luke Power, our CFO, and Russ Denton, our GC. From Eco Cypher of Deloitte, our independent auditors, also online and available to respond to appropriate questions during the Q&A portion of the meeting. The meeting will now officially come to order. I will now turn things over to Russ Denton, our General Counsel and Secretary, to proceed. Thank you, David, and welcome, Caris shareholders. Before we begin, I'd like to note that you may enter questions for the Q&A session at any time by submitting a question through the virtual meeting platform. Please refer to the rules of conduct which are on the virtual meeting platform for more information. Note that only shareholders who are logged in the meeting using their 16-digit control number will be able to vote and submit questions during today's meeting. You will also find the agenda for the meeting on the virtual meeting webpage. We will now proceed with the formal business of the meeting as set forth in the notice of annual meeting and proxy statement. It is now 10:01 A.M Central Time, and the polls are open for voting on all matters before the meeting. If you have not already voted and wish to vote, the polls will remain open until we finish presenting the proposals, at which time we will close the polls. If you have already voted, you do not need to vote again during the meeting unless you wish to change your vote. As Caris' corporate secretary, I will file proof of mailing of notice of the meeting with the records of the meeting. All shareholders of record at the close of business on April 9, 2026, or holders of a valid proxy from such a shareholder, are entitled to vote at the meeting. Next, I'd like to introduce Jim Rate of American Election Services, LLC, who has been appointed to act as Inspector of Elections at today's meeting. Mr. Rate has signed the customary oath of office to execute his duties with strict impartiality. We'll file this oath with the records of the meeting. I have been informed that a quorum is present. Therefore, I hereby declare this meeting to be duly constituted for the transaction of business. We will now proceed with the formal business of this meeting. There are two items of business to be voted on by shareholders at this meeting. The board recommends that the shareholders vote for each of these proposals. The first item of business is the election of the following 10 individuals to serve as directors of the company for a term of office expiring at the annual meeting of shareholders to be held in 2027. David Dean Halbert, Peter Castleman, Brian Brille, Dave Fredrickson, Joe Gilliam, Jon Halbert, Laurie Johansen, Dr. Lloyd Minor, Danny Phillips, and Dr. Jeffrey Vacirca. The second item of business is the ratification of the audit committee's appointment of Deloitte & Touche LLP as the independent registered public accounting firm of the company for the year ended December 31st, 2026. That was the final proposal for today's meeting. If you wish to vote and you haven't already, please vote now by clicking on the voting button on the web portal and following the instructions. You do not need to vote electronically if you've already sent in your signed proxy or if you previously voted by telephone or internet. We'll pause for approximately 15 seconds before closing the polls. It is now 10:04 A.M. Central Time on June 4th, 2026, and the polls are now closed for voting. I have received a preliminary report of the Inspector of Elections to be kept with the company's records of the annual meeting. Based on this preliminary report of the Inspector of Elections, all 10 nominees have been reelected as the company's directors, and the appointment of Deloitte as our independent registered public accounting firm for the year ending December 31st, 2026, has been ratified. The final tally of votes will be published within four business days in a current report on Form 8-K to be filed with the SEC. I will now turn things back over to David. Thank you, Russ, and thank you everyone for participating in the official business of this year's annual meeting of shareholders. This meeting is now adjourned. Now I will turn the line over to our CFO, Luke Power, for questions and answers. Thank you, David. We are now available to answer questions that are submitted online through the virtual meeting platform. Please note that we will only be answering questions that are within the parameters of the rules of conduct. As we noted earlier, only shareholders who have logged into a meeting using their 16-digit control number are able to submit a question through the question area of the web portal. Please feel free to submit your questions now. There does not appear to be any questions. I will now turn it over to David for his closing remarks. Ladies and gentlemen, this concludes our 2026 annual meeting. Thank you for attending and for your support of Caris Life Sciences. Have a great day. This concludes today's meeting. Thank you for attending. You may now disconnect and have a wonderful rest of your day.